2025-05-01 23:35:21
Latest Post
MAS Financial Services Ltd consolidated Q4FY25 PAT increases to Rs. 82.47 crores
Bandhan Bank Ltd Q4 FY2025 consolidated profit falls QoQ to Rs. 317.90 crores
Paras Defence and Space Technologies Ltd consolidated Q4 FY2025 net profit climbs to Rs. 19.72 crores
SRG Housing Finance Ltd Q4 FY2024-25 net profit up QoQ at Rs. 6.19 crores
Ajanta Pharma Ltd's consolidated profit slips QoQ to Rs. 225.26 crores
Stock Report
Emmessar Biotech and Nutrition Ltd Q3 FY2024 net profit at Rs. 12.89 lakhs
Posted On : 2024-02-04 21:18:26( TIMEZONE : IST )
EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended December 31, 2023.
Financial Results (Q3 FY2024) - QoQ Comparison
The company has reported total income of Rs. 0.8529 crores during the period ended December 31, 2023 as compared to Rs. 0.6116 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs. 0.1289 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 0.1973 crores for the period ended September 30, 2023.
The company has reported EPS of Rs. 0.26 for the period ended December 31, 2023 as compared to Rs. 0.39 for the period ended September 30, 2023.
| Financials | Q3 FY2024 | Q2 FY2024 | % Change |
| Total Income | ₹ 0.8529 crs | ₹0.6116 crs |  39.45% |
| Net Profit | ₹0.1289 crs | ₹0.1973 crs |  -34.67% |
| EPS | ₹0.26 | ₹0.39 | -33.33% |
Financial Results (Q3 FY2024) - YoY Comparison
The company has reported total income of Rs. 0.8529 crores during the period ended December 31, 2023 as compared to Rs.0.8721 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.0.1289 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.-0.0220 crores for the period ended December 31, 2022.
The company has reported EPS of Rs.0.26 for the period ended December 31, 2023 as compared to Rs.-0.04 for the period ended December 31, 2022.
| Financials | Q3 FY2024 | Q3 FY2023 | % Change |
| Total Income | ₹ 0.8529 crs | ₹0.8721 crs | -2.20% |
| Net Profit | ₹0.1289 crs | ₹-0.0220 crs | 685.91% |
| EPS | ₹0.26 | ₹-0.04 | 750.00% |
Financial Results (9 Months Ended FY2024) - YoY Comparison
The company has reported total income of Rs.1.9878 crores during the 9 Months period ended December 31, 2023 as compared to Rs.2.0207 crores during the 9 Months period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.0.3811 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.0.3081 crores for the 9 Months period ended December 31, 2022.
The company has reported EPS of Rs.0.76 for the 9 Months period ended December 31, 2023 as compared to Rs.0.62 for the 9 Months period ended December 31, 2022.
| Financials | 9 Months Ended FY2024 | 9 Months Ended FY2023 | % Change |
| Total Income | ₹1.9878 crs | ₹2.0207 crs | -1.63% |
| Net Profit | ₹0.3811 crs | ₹0.3081 crs | 23.69% |
| EPS | ₹0.76 | ₹0.62 | 22.58% |
Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 30.56 as compared to the previous close of Rs. 30.28. The total number of shares traded during the day was 7898 in over 80 trades.
The stock hit an intraday high of Rs. 31.50 and intraday low of 29.31. The net turnover during the day was Rs. 239262.00.
